Search Results - "DIAZ, Ricardo S"

Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine by Hager, Karen J., Pérez Marc, Gonzalo, Gobeil, Philipe, Diaz, Ricardo S., Heizer, Gretchen, Llapur, Conrado, Makarkov, Alexander I., Vasconcellos, Eduardo, Pillet, Stéphane, Riera, Fernando, Saxena, Pooja, Geller Wolff, Priscila, Bhutada, Kapil, Wallace, Garry, Aazami, Hessam, Jones, Christine E., Polack, Fernando P., Ferrara, Luciana, Atkins, Judith, Boulay, Iohann, Dhaliwall, Jiwanjeet, Charland, Nathalie, Couture, Manon M.J., Jiang-Wright, Julia, Landry, Nathalie, Lapointe, Sophie, Lorin, Aurélien, Mahmood, Asif, Moulton, Lawrence H., Pahmer, Emmy, Parent, Julie, Séguin, Annie, Tran, Luan, Breuer, Thomas, Ceregido, Maria-Angeles, Koutsoukos, Marguerite, Roman, François, Namba, Junya, D’Aoust, Marc-André, Trepanier, Sonia, Kimura, Yosuke, Ward, Brian J.

“…In this trial involving more than 24,000 participants, the efficacy of two doses of a viruslike-particle, plant-based vaccine with adjuvant was 69.5% against…”
Get full text

Individual factors associated with time to non-adherence to ART pick-up within HIV care and treatment services in three health facilities of Zambézia Province, Mozambique by Filimão, Dércio B C, Moon, Troy D, Senise, Jorge F, Diaz, Ricardo S, Sidat, Mohsin, Castelo, Adauto

“…Mozambique has made significant gains in addressing its HIV epidemic, yet adherence to visit schedules remains a challenge. HIV programmatic gains to date…”
Get full text

Differential Persistence of Transmitted HIV-1 Drug Resistance Mutation Classes by Jain, Vivek, Sucupira, Maria C., Bacchetti, Peter, Hartogensis, Wendy, Diaz, Ricardo S., Kallas, Esper G., Janini, Luiz M., Liegler, Teri, Pilcher, Christopher D., Grant, Robert M., Cortes, Rodrigo, Deeks, Steven G., Hecht, Frederick M.

“…Background. Transmitted human immunodeficiency virus type 1 (HIV-1) drug resistance (TDR) mutations can become replaced over time by emerging wild-type viral…”
Get full text

Detection of coinfection with Chikungunya virus and Dengue virus serotype 2 in serum samples of patients in State of Tocantins, Brazil by dos Santos S. Marinho, Robson, Sanz Duro, Rodrigo L., Santos, Giulia L., Hunter, James, da Aparecida Rodrigues Teles, Maria, Brustulin, Rafael, de Padua Milagres, Flavio A., Sabino, Ester C., Diaz, Ricardo S., Komninakis, Shirley V.

“…The co-circulation of Chikungunya (CHIKV), Dengue (DENV) and Zika (ZIKV) viruses increased the risk of outbreaks and coinfections among them. Here, we report…”
Get full text

Prevalence, incidence density, and genotype distribution of GB virus C infection in a cohort of recently HIV-1-infected subjects in Sao Paulo, Brazil by Giret, Maria Teresa M, Miraglia, João Luiz, Sucupira, Maria Cecília Araripe, Nishiya, Anna, Levi, José Eduardo, Diaz, Ricardo S, Sabino, Ester C, Kallas, Esper G

“…The results of previous studies elsewhere have indicated that GB virus C (GBV-C) infection is frequent in patients infected with the human immunodeficiency…”
Get full text

Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal by Legrand, Fatema A, Nixon, Douglas F, Loo, Christopher P, Ono, Erika, Chapman, Joan M, Miyamoto, Maristela, Diaz, Ricardo S, Santos, Amélia M N, Succi, Regina C M, Abadi, Jacob, Rosenberg, Michael G, de Moraes-Pinto, Maria Isabel, Kallas, Esper G

“…In utero transmission of HIV-1 occurs on average in only 3%-15% of HIV-1-exposed neonates born to mothers not on antiretroviral drug therapy. Thus, despite…”
Get full text

HIV-1 Proviral DNA Loads (as Determined by Quantitative PCR) in Patients Subjected to Structured Treatment Interruption after Antiretroviral Therapy Failure by KOMNINAKIS, Shirley V, SANTOS, Domingos E. M, SANTOS, Carlos, OLIVEROS, Marcia P. R, SANABANI, Sabri, DIAZ, Ricardo S

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Effect of Natural Polymorphisms in the HIV-1 CRF02_AG Protease on Protease Inhibitor Hypersusceptibility by Santos, André F. A, Tebit, Denis M, Lalonde, Matthew S, Abecasis, Ana B, Ratcliff, Annette, Camacho, Ricardo J, Diaz, Ricardo S, Herchenröder, Ottmar, Soares, Marcelo A, Arts, Eric J

“…Hypersusceptibility (HS) to inhibition by different antiretroviral drugs (ARVs) among diverse HIV-infected individuals may be a misnomer because clinical…”
Get full text

Correction: Unexpected Diversity of Cellular Immune Responses against Nef and Vif in HIV-1-Infected Patients Who Spontaneously Control Viral Replication by Tarosso, Leandro F., Sauer, Mariana M., Sanabani, Sabri, Giret, Maria Teresa, Tomiyama, Helena I., Sidney, John, Piaskowski, Shari M., Diaz, Ricardo S., Sabino, Ester C., Sette, Alessandro, Kalil-Filho, Jorge, Watkins, David I., Kallas, Esper G.

Get full text

Prevalence of transmitted HIV‐1 antiretroviral resistance among patients initiating antiretroviral therapy in Brazil: a surveillance study using dried blood spots by Moraes Soares, Celina M P, Vergara, Tania R C, Brites, Carlos, Brito, Jose D U, Grinberg, Gorki, Caseiro, Marcos M, Correa, Carlos, Suffert, Theodoro A, Pereira, Flavio R, Camargo, Michelle, Janini, Luiz M, Komninakis, Shirley, Sucupira, Maria C A, Diaz, Ricardo S

“…Introduction In Brazil, the use of antiretrovirals is widespread: more than 260,000 individuals are currently undergoing treatment. We conducted a survey…”
Get full text

High human herpesvirus 8 (HHV-8) prevalence, clinical correlates and high incidence among recently HIV-1-infected subjects in Sao Paulo, Brazil by Batista, Mariana Dias, Ferreira, Suzete, Sauer, Mariana M, Tomiyama, Helena, Giret, Maria Teresa Maidana, Pannuti, Cláudio S, Diaz, Ricardo S, Sabino, Ester C, Kallas, Esper G

“…Human herpesvirus 8 (HHV-8) is the etiological agent for Kaposi Sarcoma, which occurs especially in HIV-infected subjects. HHV-8 infection and its clinical…”
Get full text

A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil by SOARES, Marcelo A, DE OLIVEIRA, Tulio, TEIXEIRA, Paulo R, CASSOL, Sharon, TANURI, Amilcar, BRINDEIRO, Rodrigo M, DIAZ, Ricardo S, SABINO, Ester C, BRIGIDO, Luis, PIRES, Ivone L, MORGADO, Mariza G, DANTAS, Maria C, BARREIRA, Draurio

“…To characterize the subtype C strains of HIV type 1 that circulate in Brazil, especially those originated from the southern part of the country. One hundred…”
Get full text

Pre-Exposure Prophylaxis Failure With a Multiple Drug-Resistant HIV-1 Clade C Virus in Brazil by Diaz, Ricardo S., Grangeiro, Alexandre, Estevam, Denize L., Galinskas, Juliana, Dias, Danilo, Schechter, Mauro

Get full text

Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication by Tarosso, Leandro F, Sauer, Mariana M, Sanabani, Sabri, Giret, Maria Teresa, Tomiyama, Helena I, Sidney, John, Piaskowski, Shari M, Diaz, Ricardo S, Sabino, Ester C, Sette, Alessandro, Kalil-Filho, Jorge, Watkins, David I, Kallas, Esper G

“…HIV-1-infected individuals who spontaneously control viral replication represent an example of successful containment of the AIDS virus. Understanding the…”
Get full text

Cardiometabolic health in people with HIV: expert consensus review by Batterham, Rachel L, Bedimo, Roger J, Diaz, Ricardo S, Guaraldi, Giovanni, Lo, Janet, Martínez, Esteban, McComsey, Grace A, Milinkovic, Ana, Naito, Toshio, Noe, Sebastian, O'Shea, Donal, Paredes, Roger, Schapiro, Jonathan M, Sulkowski, Mark S, Venter, François, Waters, Laura, Yoruk, Ilksen Ungan, Young, Benjamin

“…To develop consensus data statements and clinical recommendations to provide guidance for improving cardiometabolic health outcomes in people with HIV based on…”
Get full text

Comparative effectiveness of dried plasma HIV-1 viral load testing in Brazil using ViveST for sample collection by Zanoni, Michelle, Cortes, Rodrigo, Diaz, Ricardo S, Sucupira, M. Cecilia, Ferreira, Denise, Inocencio, Lilian A, Vilhena, Cintia, Loveday, Clive, Lloyd, R.M, Holodniy, M

“…Abstract Background Utilization of dried plasma for HIV-1 viral load testing would significantly decrease sample shipping costs. Objectives To describe the…”
Get full text

Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study by Lataillade, Max, Lalezari, Jacob P, Kozal, Michael, Aberg, Judith A, Pialoux, Gilles, Cahn, Pedro, Thompson, Melanie, Molina, Jean-Michel, Moreno, Santiago, Grinsztejn, Beatriz, Diaz, Ricardo S, Castagna, Antonella, Kumar, Princy N, Latiff, Gulam H, De Jesus, Edwin, Wang, Marcia, Chabria, Shiven, Gartland, Margaret, Pierce, Amy, Ackerman, Peter, Llamoso, Cyril

“…Fostemsavir, a prodrug of the first-in-class attachment inhibitor, temsavir, is indicated for heavily treatment-experienced individuals with…”
Get full text

Patient-Derived HIV-1 Nef Alleles Reveal Uncoupling of CD4 Downregulation and SERINC5 Antagonism Functions of the Viral Pathogenesis Factor by Obermaier, Benedikt, Ananth, Swetha, Tibroni, Nadine, Pierini, Virginia, Shytaj, Iart L., Diaz, Ricardo S., Lusic, Marina, Fackler, Oliver T.

Get full text

Nitric oxide stimulates a PKC-Src-Akt signaling axis which increases human immunodeficiency virus type 1 replication in human T lymphocytes by Curcio, Marli F., Batista, Wagner L., Castro, Eloísa D., Strumillo, Scheilla T., Ogata, Fernando T., Alkmim, Wagner, Brunialti, Milena K.C., Salomão, Reinaldo, Turcato, Gilberto, Diaz, Ricardo S., Monteiro, Hugo P., Janini, Luiz Mário R.

“…Human immunodeficiency virus (HIV) infections are typically accompanied by high levels of secreted inflammatory cytokines and generation of high levels of…”
Get full text

Vicriviroc plus optimized background therapy for treatment-experienced subjects with CCR5 HIV-1 infection: Final results of two randomized phase III trials by Caseiro, Marcos M, Nelson, Mark, Diaz, Ricardo S, Gathe, Joseph, de Andrade Neto, Jose L, Slim, Jihad, Solano, Antonio, Netto, Eduardo M, Mak, Carmen, Shen, Junwa, Greaves, Wayne, Dunkle, Lisa M, Vilchez, Regis A, Zeinecker, Jennifer

“…Summary Background Vicriviroc, a novel HIV CCR5 antagonist, demonstrated significant efficacy and favorable tolerability in phase II trials in…”
Get full text